Carbohydrate antigen 724 (CA724), alpha-fetoprotein (AFP), neuron-specific enolase (NSE), and carbohydrate antigen 211 (CA211) are instrumental in tumor progression, and their clinical value in patients with gastrointestinal cancer has been reported [17,18,19,20,21]. This evidence concerns the gene ENO2 and neoplasm.